You can help us change the way we treat overactive bladder. Right now, 60 million people in the U.S. deal with this condition, and treatments don't work the same for everyone. We think mental health, mood, and sleep might play a role, and we need your help to figure it out! All you need to do is answer some quick questions about your bladder, mood, and sleep before treatment starts and once more 2-4 months later. Your input could show us how improving mental well-being could make overactive bladder treatments work better.

We are interested in talking to people with chronic non-cancer pain about their experiences of receiving treatment, especially times that they felt particularly empowered or disempowered. Participation includes one focus group lasting 60 to 90 minutes.

Do you have moderate to severe plaque psoriasis? If so, you may qualify for a clinical research study evaluating an investigational treatment for plaque psoriasis.

Are you interested in learning about your sleep, satiety, energy, and cognition? Interested in protein? You may be able to participate in a research study to find out how a plant-based protein, creatine, and fiber supplement may impact those outcomes.

Do you have Crohn's disease and painful period cramps? You may be able to join a research study. We want to learn which pain medicine works best and is safest for people with Crohn's disease.

Do you identify as Hispanic? Do you regularly buy beverages for your household? If so, you may be eligible to participate in a research study about what makes people decide to buy things in a convenience store. Compensation provided.

The purpose of this research is to learn whether the investigational study drug BMS-986504 works to treat metastatic (cancer that has spread in the body) pancreatic ductal adenocarcinoma (PDAC) when combined with standard chemotherapy in participants with homozygous MTAP deletion or MTAP loss, who have not previously received treatment for metastatic PDAC.

This study is being conducted to see how well a study drug called ponsegromab works and if it might improve health and quality of life compared to a placebo in adults who have cachexia (a condition causing significant unintentional weight loss and muscle wasting) and metastatic pancreatic cancer, for which they receive initial chemotherapy.

Are you a Korean speaker living in the U.S. who has used a medical interpreter in a hospital? We are conducting a study to learn about your communication experiences with interpreters and healthcare providers. You can choose to complete a short online survey or participate in a one-on-one interview in Korean. You may enter a drawing based on chance in which each participant has equal odds of receiving the incentive for the survey and receive a gift card for participating in the interview. The study has been modified to broaden the survey participant criteria to include individuals who have not used medical interpreter services, in addition to those who have.

We're doing this study to understand how a type of genetic material called DNA in the blood changes in people with a specific type of cancer that has spread to only a few places in the body. By looking at how this DNA behaves before and after cancer treatment, including radiation, we aim to learn more about how the cancer responds. To do this, we'll collect blood and tumor samples from you to analyze what's happening. This could help in better understanding and improving cancer treatments for others in the future.